Erratum
for
Kaminski et al., J Clin Oncol 23 (31) 7985-7993.
Journal of Clinical Oncology, Vol 24, No 1 (January 1), 2006: pp. 212
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.11.004
ERRATUM
The November 1, 2005, article by Kaminski et al, titled "Re-Treatment With I-131 Tositumomab in Patients With Non-Hodgkin’s Lymphoma Who Had Previously Responded to I-131 Tositumomab" (J Clin Oncol 23:7985-7993, 2005) contained inaccurate information in the Authors’ Disclosures of Potential Conflicts of Interest section. The corrected version is reprinted below in its entirety. The online version has been corrected in departure from the print.
Authors' Disclosures of Potential Conflicts of Interest
Although all authors completed the disclosure declaration, the following authors or their immediate family members indicated a financial interest. No conflict exists for drugs or devices used in a study if they are not being evaluated as part of the investigation. For a detailed description of the disclosure categories, or for more information about ASCO's conflict of interest policy, please refer to the Author Disclosure Declaration and the Disclosures of Potential Conflicts of Interest section in Information for Contributors.
| Authors |
Employment |
Leadership |
Consultant |
Stock |
Honoraria |
Research Funds |
Testimony |
Other |
|
| Mark S. Kaminski |
|
|
Corixa Corporation (B) |
|
Corixa Corporation (B); GlaxoSmithKline (B) |
Corixa Corporation (B) |
Corixa Corporation (N/R); GlaxoSmithKline (N/R) |
|
| Stephanie A. Gregory |
|
|
|
|
Corixa Corporation (A); GlaxoSmithKline (A) |
Corixa Corporation (A) |
|
|
| John P. Leonard |
|
|
Corixa Corporation (B); GlaxoSmithKline (A) |
|
Corixa Corporation (B); GlaxoSmithKline (A) |
Corixa (C) |
|
|
| Susan J. Knox |
Corixa Corporation (N/R) |
|
IDEC (A); Corixa Corporation (A) |
|
IDEC (A); Corixa Corporation (A) |
IDEC (B); Corixa Corporation (B) |
|
|
| Stewart Kroll |
Corixa Corporation (N/R) |
|
|
Corixa Corporation (B) |
|
|
|
| Richard L. Wahl |
GlaxoSmithKline (N/R) |
|
Corixa Corporation (B); GlaxoSmithKline (B) |
|
GlaxoSmithKline (A); Corixa Corporation (A) |
Corixa Corporation (C) |
GlaxoSmithKline (N/R) |
|
|
Dollar Amount Codes (A) < $10,000 (B) $10,000-99,999 (C)  $100,000 (N/R) Not Required
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
|
